Empyema rarely complicates pneumonia. In a 361-bed regional pediatric hospital, 50 pleural empyemas were identified from 1988 through 1994; 17 (34%) occurred in the last 12 months of this period, for which the incidence was 3.3 per 100,000 of the population aged~18 years (P < .05, r test). A significant seasonal prevalence was observed: 50% of cases occurred in the winter (P < .001, r test). In contrast with the findings of previous studies, in which empyemas predominantly occurred in infants, the median age of our patients was 7 years; underlying illnesses were present in only 10%, and all had community-acquired disease. Eighty-two percent had chest tubes inserted, 56% required a thoracotomy with pleural decortication, and 2% had a lobectomy. There were no deaths. Streptococcus pneumoniae was isolated in 40% of the cases; specimens in 44% of the cases were sterile. None of the empyemas were associated with Staphylococcus aureus or Haemophilus influenzae type b, and only one was caused by group A streptococcus. Among 13 S. pneumoniae isolates, the rate of resistance to penicillin was 15%; to erythromycin, 15%; to chloramphenicol, 31%; and to cefotaxime, 23%. The penicillin-resistance rate among blood and cerebrospinal fluid pneumococcal isolates was 17% during 1993-1994. Drug-resistant S. pneumoniae is now a recognized cause of pleural empyemas in children.
em 1996; 22 (June) tures. Pleural fluid aspirates were frequently examined for determination of pH, WBC count, and concentrations of glucose, protein, and lactate dehydrogenase. Appropriate bacterial stains and cultures were also performed. In addition, many cases were investigated with CT and ultrasonographic evaluations of the chest.
Empyema complicating pneumonia was defined by the presence of one major criterion or two minor criteria. Major criteria included the following factors: the presence of pus (noted by visual inspection) in the pleural space; the performance of pleural decortication in association with a compatible clinical picture; and the positivity of a pleural fluid culture. Minor criteria included the following laboratory values or findings: pleural fluid pH,~7.2; glucose,~40 mg/dL; WBCs, 10,000/dL; lactate dehydrogenase,~1,000 U/L; and blood culture, positive.
Additional factors were evaluated for the patients who met these criteria for empyema. These factors included patient demographics; season and year of admission; concurrent antibiotic use; clinical presentation; reports concerning chest radiographs, CT scans, and u1trasonographic evaluations; sites of infection; antibiotic treatment; surgical management; and clinical outcome.
The criteria developed by the Centers for Diseases Control and Prevention (CDC) were utilized to distinguish nosocomial from community-acquired pneumonias and empyemas [19] . In brief, pneumonia was defined by a constellation of clinical, radiographic, and laboratory findings [19] . Pneumonia that was already present or in the incubation phase at the time ofhospitalization was considered community-acquired [19] . All cases ofpleural empyema that developed as an extension of pneumonia that was present on admission were designated as community-acquired [19] .
Microbiology. Pleural fluid aspirates and blood were cultured by standard techniques [20] . Anaerobic cultures were performed when requested. Antibiotic susceptibility testing for S. pneumoniae was performed by the methods of the National Committee for Clinical Laboratory Standards [21, 22] . Antimicrobial susceptibility was defined with use of the following MIC breakpoints: penicillin,~0.06 J.lg/mL; chloramphenicol, 4 J.lg/mL; cefuroxime,~0.5 J.lg/mL; erythromycin,~0.5 J.lg/mL; cefotaxime,~0.5 J.lg/mL; and ceftriaxone,~0.5 J.lg/mL [22] .
Pneumococci were stored on sheep blood at -70°C. Pneumococci from empyema cases were later retrieved from the archival collection and retested by the Etest (AB BIODISK, Solna, Sweden) for antimicrobial susceptibility patterns, with use of 1994 criteria [22] . The isolates were then shipped to the CDC for serotyping in the laboratory of Richard Facklam, Ph.D., on the basis of capsular swelling with type-specific antisera (Quellung reaction) [23] . The concurrent etiologic trends with regard to cases of community-acquired bacteremia due to S. aureus, S. pneumoniae, and H influenzae type b were also examined.
Surgery. Indications for chest tube placement included imminent respiratory failure, mediastinal shift, or large pleural effusions. Criteria for chest tube removal included the following findings: <50 mL of drainage over 24 hours, absence ofbronchopleural fistulae, and reexpansion of the lung (as evidenced with repeated chest radiography). Decortication was performed in children who had persistent fever while receiving appropriate antibiotics, persistent respiratory difficulties, prolonged chest tube drainage, a thick pleural rind prohibiting lung reexpansion or chest tube drainage, and/or bronchopleural fistulae. The decortication procedure included thoracoscopy or muscle-sparing posterolateral thoracotomy with debridement of the involved visceral and parietal pleura, followed by closed chest tube drainage.
Data analysis. Data on the patient demographics and clinical and laboratory parameters were entered into the statistical program Epi-Info 5.1 [24] and analyzed by univariate methods.
Results
The hospital charts of 270 patients whose coded diagnosis was pleural effusion or empyema and who were treated during the period of July 1988 through June 1994 were reviewed. Two hundred and ten patients had pleural effusions; 50 met the criteria for empyema and inclusion in our study ( figure 1) .
Patient demographics. Among the 50 cases evaluated for pleural empyemas, 29 (58%) involved males. Their ages ranged from 1 year (in three cases) to 20 years (~15 years in three cases). Median age was 7 years (first quartile, 3 years; third quartile, 11 years). All cases were community-acquired [19] . Although four patients were transferred from other hospitals, none ofthem had nosocomial disease. The duration ofhospitalization ranged from 3 to 32 days (median, 12 days; mean, 13 days; first quartile, 8 days; third quartile, 15 days).
The majority of the children were previously healthy. Five (10%) had underlying illnesses (one case each of Bruton's agammaglobulinemia, trisomy 21 (Down's) syndrome, disseminated rhabdomyosarcoma, physical abuse, and cerebral palsy with seizures). None of the cases followed blunt or penetrating trauma, surgical procedures, spontaneous pneumothorax, esophageal perforation, thoracocentesis, or subdiaphragmatic infections.
Clinicalfeatures. The majority of the children had persistent symptoms despite antibiotic therapy for community-acquired pneumonia. Symptoms included spiking fevers in 47 cases (94%). The mean highest temperature was 103.6°F. Duration of fever ranged from 1 to 30 days (median, 5 days). Cough was reported in 34 cases (68%), dyspnea in 15 (30%), and pleuritic chest pain in 16 (32%). Forty-three patients (86%) had significantly elevated WBC counts (range, 12,000-58,000/ dL; median, 17,500/dL). The majority had neutrophilia.
Chest radiology. Some patients' initial chest radiographs did not suggest effusions, but later radiographic studies revealed them. Reports concerning chest radiographs (posterior-anterior 
Other (n=60) Figure 1 . A flow chart describing the 210 cases ofpleural effusions reviewed, of which 50 met the definition of empyema and were included in the study.
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and lateral decubitus views) revealed pneumonic consolidation with effusion in all 50 cases. Thirty-two cases (64%) involved the right lung, while 18 (36%) involved the left lung. The most commonly affected consolidated lobes were the right middle and right lower lobes (in 14 cases each). Confirmatory CT of the chest was performed in 17 cases and revealed loculated empyemas in five. Reports concerning ultrasonograms of the chest for another 13 cases revealed multiple loculations in nine. Microbiology. A bacterial etiology was confirmed for 28 empyemas (56%) (table 1). Twenty-one children (42%) had a positive pleural fluid culture, while 10 children (20%) had a positive blood culture. S. pneumoniae was the most common isolate (40%); seven of the 20 pneumococcal empyemas were identified within the last year studied. There were no cases due to S. aureus or H influenzae type b. Only one polymicrobial case was identified (table 1) . Coagulase-negative staphylococcus and viridans streptococcus were included as true pathogens, because they were isolated within 24-48 hours of culture and were associated with significant disease. Anaerobic bacteria were not isolated.
Serotyping of 13 pneumococci revealed type 14 (in 4 cases), type 1 (4 cases), and types 5, 6B, 9V, 19A, and 23F (1 case each). The etiologic trends associated with nonduplicate isolates of S. pneumoniae, S. aureus, and H. influenzae type b in the cases of bacteremia studied are compared in figure 2 .
Antibiotic-resistant S. pneumoniae. The rate of resistance to penicillin among invasive S. pneumoniae isolates from CSF or blood was 17% (18 of 105 isolates) in 1993 and 17% (17 of 99) in 1994; the patterns of resistance to other antimicrobials are listed in table 2. Thirteen of the 20 (nonduplicate) pneumococcal isolates from our empyema cases were available for retesting of antibiotic susceptibility [22] . Two strains (15%) that were isolated in 1993 and 1994 were resistant to penicillin: one was intermediately resistant (MIC, 0.12 j.£g/mL), while the other was highly resistant (MIC, 4 j.£g/mL).
Previous antibiotic treatment.
Thirty children (60%) were receiving 46 dosages of antibiotics (in various combinations) for community-acquired pneumonia at the time of the pleural fluid tap. Previous antibiotic treatment in the community (before thoracocentesis) was significantly associated with sterile empyemas (15 of22) in comparison with pneumococcal empyemas (7 of 20; P :5 .03 per Fisher's exact test) (table 3) . Duration of previous antibiotic therapy was longer for those with sterile empyemas (range, 2-14 days; median, 6 days) than for those with pneumococcal empyemas (1-2 days) . Regarding previous antibiotic therapy in the community, cefuroxime (9), ceftriaxone (7), penicillin analogues (8), and erythromycin (7) were the most common antibiotic choices for all cases.
Antibiotic therapy. Empirical broad-spectrum parenteral antibiotic therapy for pleural empyemas was commenced after the appropriate cultures were performed. Antibiotic regimens 1989-1990 1990-1991 1991-1992 1992-1993 1993-1994 Year of diagnosis were later modified when culture and susceptibility reports were available. Initial antibiotic therapies (on admission) were compared for pneumococcal (20) and sterile empyemas (22) (table 3) . Cefuroxime was used in 95% of those cases due to pneumococci, whereas the semisynthetic penicillins (40%) and cefuroxime (41 %) were most frequently prescribed for sterile empyemas. Ceftriaxone and cefotaxime were used only in the patients with sterile empyemas, possibly in anticipation ofpenicillin-resistant pneumococcal strains.
Outcome. Forty-one children (82%) required surgical interventions. ill all 41, chest tubes were placed on admission (before antibiotic therapy commenced) or during the course of hospitalization. All 17 patients presenting during the last year studied had chest tubes inserted. The total duration of chest tube drainage was 2-30 days (median, 6 days; mean, 7 days). Two cases required repeated chest tube placement or aspiration thoracoscopy. Twenty-eight (56% of 50) were severe enough to require a thoracotomy with pleural decortication. A thick pleural rind was reported in all of the cases. One child's course was complicated by a large lung abscess and air leak, which required lobectomy. Two others were intubated and cared for in the pediatric intensive care unit for respiratory distress at the time of presentation for empyema. One of them had a cardiac arrest. Four children had restrictive or obstructive lung disease, which was discovered by pulmonary function testing during follow-up. There were no deaths.
Changes in incidence as related to season and geography. The incidence of pleural empyemas in children varied from 0.6 to 3.3 per 100,000 of the pediatric population in Greater Cincinnati during the period of 1988 to 1994. Seventeen (34%) of the 50 empyema cases were diagnosed in the last year of the study, compared with .-;;; 10 in each of the previous 5 years (figure 3). A X 2 test for linear trend showed that this apparent increase was significant (X 2 = 4.64, 1 df, P < .05).
A significant seasonal prevalence was also observed: 25 (50%) of the cases were identified during the winter, 12 (24%) in spring, 11 (22%) in autumn, and 2 (4%) in summer. A X 2 test revealed that the seasonal frequencies were not the same (X 2 = 21,3 df, P < .001). Mapping of the empyema cases by Greater Cincinnati zip codes revealed no evidence of temporalspatial clustering (Atlas Geographic Information Systems, Strategic Mapping, San Jose, CA).
Discussion
This study suggests a significant recent increase in the incidence of pleural empyemas in children in Cincinnati. Among 50 cases identified in the 6-year study period, 34% were diagnosed in the last year, yielding an incidence of 3.3 cases per 100,000 children. Although the definition of empyema can be difficult, we believe these results represent a true increase, as
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.. ... Forty percent of our bacterial isolates were S. pneumoniae. Only one isolate of group A streptococcus was recovered, and there was a notable absence of H. influenzae type band S. aureus. This contrasts with previously published reports of pediatric investigations in which these organisms were predominant isolates. Fourteen pooled studies of pleural empyemas in children over the past decade, representing 1,142 diagnostic thoracocenteses, demonstrated S. aureus to be the primary isolate in 25% of the cases; other bacteria included S. pneumoniae (14%), H. influenzae type b (7%), anaerobes (6%), other streptococcal species (7%), and other bacteria (9%); the remaining cultures were sterile (32%) [10, 11, 17, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .
The absence of H. injiuenzae type b isolates from empyemas may be partly explained by the recent widespread use of the effective H. influenzae type b vaccine, administered at 2, 4, and 6 months of age. A recent report noted that > 70% of 227 children with parapneumonic effusions and empyema were <2 years of age [10] , and their pleural fluid yielded S. aureus or H. influenzae type b. Previous reports have emphasized the occurrence of pleural empyemas in infants and young children; the older age (median, 7 years) in our empyema cases is consistent with the predominantly pneumococcal etiology observed.
The local etiologic trends associated with bacteremia in children also mimic this etiologic finding. The significant occurrence of pleural empyemas in the influenza/winter season (50%) would also support a pneumococcal etiology [36] . Some of the sterile empyemas may have been linked to anaerobic organisms. While anaerobic pleural empyema is less common in children than in adults, Fajardo and Chang isolated anaerobes in 7% of 71 cases involving children [11] .
Although a few case reports have demonstrated S. pneumoniae as a primary isolate from pleural fluid [29, 34] , none of the cases were associated with drug-resistant organisms. At CHMC, among 13 pneumococcal empyema isolates, the rate of resistance to penicillin was 15%; to chloramphenicol, 31 %; to erythromycin, 15%; and to cefotaxime, 23%. Cases ofpneumonia involving a prolonged, complicated course and sterile empyema and blood cultures may also have been caused by drug-resistant pneumococci; duration of antibiotic therapy preceding thoracocentesis was longer in cases of sterile vs. pneumococcal empyemas, and cefuroxime or ceftriaxone may have been effective in eradicating such strains.
During 1993-1994, the endemic rate of penicillin resistance was 17% among pneumococcal isolates from blood or CSF. Within the same period, resistance rates were 2%-10% for cefuroxime and zero to 5% for ceftriaxone. Comparatively (also during 1993-1994), the prevalence of penicillin resistance among 406 invasive pneumococcal isolates was zero to 35% (mean, 14%) at nine other children's hospitals in the United States; cephalosporin resistance was observed in 4% of the isolates [37] .
Only two of our cases were severe enough to require intensive care (without thoracotomy), and there were no deaths. In contrast, the high mortality rates among infants (which previously approached 50% [38] ) have declined over the past 4 decades ofthe antibiotic era, although recent death rates remain significant at 4%-12% [4, II) . The zero mortality rate among our cases may be related to the significant absence of (I) infants among the patients studied [39] ; (2) nosocomial infections, which are associated with a death rate of 33% [11] ; (3) disease caused by S. aureus [10] ; (4) polymicrobial infection [11, 18] A recent report from Barcelona and data from South Africa showed mortality was not linked to in vitro antibiotic resistance in cases of pneumococcal pneumonia and other invasive infections outside of the CNS [14, 16, 18] . Although controversial [29, [31] [32] [33] [34] , another factor is the early and aggressive surgical intervention with tube thoracostomies and pleural decortication, which may hasten recovery from severe empyema [29] . The decortication rate was high (56% of 50 cases), but our criteria for surgical intervention to prevent "trapped lung" syndrome were not different. These cases may represent a more aggressive form of the disease. Nosocomial acquisition of pneumococcal pneumonia in patients with underlying disease was a risk factor for pneumococcal infection in Barcelona [18] , but this was not observed in our series.
In summary, our data suggest an increase in the incidence of pleural empyemas in children. Most were linked to pneumococci, of which some were multiply drug-resistant. Simultaneously, 17% of invasive blood and CSF pneumococcal isolates were also resistant to penicillin, our first-line therapy for bronchopulmonary pneumonia.
Interim recommendations might include judicious selection of an antibiotic with the narrowest possible spectrum for the outpatient management of community illnesses, especially pneumonia, and to control the problem of pneumococcal resistance. Careful follow-up is needed for consideration of the necessity of diagnostic lung punctures [39] or bronchoalveolar lavage [41] . Identification of empyema in its early stages also enables the use of thoracocentesis for efficient isolation of the appropriate bacteria, to define resistance patterns, and to guide drug therapy for the best outcomes.
High-dose penicillin, clindamycin, third-generation cephalosporins, or vancomycin may be considered for the effective treatment of drug-resistant pneumococcal empyemas. Most of the serotypes encountered in pneumococcal empyemas are included in the 23-valent pneumococcal vaccine, which prevents invasive complications in at-risk children. Newer antimicrobials and acceleration of the licensing of new conjugate pneumococcal vaccines [42, 43] may be needed.
Physicians should be aware of this possible change in the epidemiology of pleural empyema in children, especially in this era of rapidly emerging worldwide antibiotic resistance to S. pneumoniae.
